companydata.dkcompanydata.dk

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S: Financial statements 2018

CVR: 33249098

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S (CVR 33249098) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,317,781 and a net result of DKK 954,488 compared with DKK 1,971,520 the year before. That is a decrease of 53.9% compared with the year before. Equity in the 2018 report amounted to DKK 1,460,326. The solvency ratio was 16.6%.

Gross Profit
DKK 1,317,781
Profit/Loss
DKK 954,488
Equity
DKK 1,460,326
Total Assets
DKK 8,781,850
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-1.3 mio.954 t.1.5 mio.0
2017-2.9 mio.2 mio.3 mio.-
2016-16 mio.11.1 mio.12 mio.-
2015-60.4 mio.45.4 mio.46 mio.-
2014-42 mio.32.4 mio.38.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S appoints new auditorSep 4, 2018

As of September 4, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.

Auditor steps down at NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/SSep 4, 2018

As of September 4, 2018, AIDER Godkendt Revisionsaktieselskab has stepped down as auditor of NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S.

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S: The 2017 annual report is outApr 9, 2018

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S has published its annual report for 2017. Gross profit came to DKK 2,860,959, and the net result was DKK 1,971,520.

About NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S

NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 2010. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK 248,136 and a net result of DKK 164,772 compared with DKK 954,488 the year before. Equity in the 2019 report amounted to DKK 725,098.

Source: annual report 2019, Danish Business Authority

Other financial years